Boparan - The Henhouse In Order, For Now - Model Update

All,

Please find our model update of Boparan here.

Note: Beta testers can check Boparan on the portal here.

Boparan have done really well deleveraging over the last year despite operational performance falling short of the mark. The key question is what happens now that it is embarking on a capex cycle and how cash flow will hold up against this backdrop. We see quite a large ramp-up in capex plans leading to weakening FCF levels in the coming years. But retail market participants (grocers in particular) are not ready to digest further price increases. At 105c/€, we don't see much price action and thus limited value in building a position in this name. 

Investment Rationale

  • We have not taken a position in the Boparan SSNs. The bonds trade at 105p/£ and are callable at 102.3 in Nov-27 or Par thereafter. We do expect this bond to be called next year, as the Group would find it easier to refinance before metrics worsen further. In this scenario, we see a potential 2pts of downside. This is a very small sum for which to be entering a short, therefore, we remain on the sidelines for this name.

  • After a good few quarters of deleveraging, Boparan is going into a phase of weakening metrics: margins being capped and capex rising, which will impair FCF for at least two years; however, it does start from a strong base, due to the aforementioned deleveraging.

  • We remain cautious because of the potential for transfer pricing as a vertically-integrated operator in the market with multiple transactions with related parties. This is now even more a concern with the sale of its 50% stake in Hook 2 Sisters to the Boparan Family office.

  • Our DCF calculations show just under £1bn of equity below the bonds and an EV of £1.4bn, or 8.6x  forward EBITDA.

Key Conclusions

  • Boparan is going through a period now of capped margins and capex ramp-up, leading to weakening cash flows and leverage creeping back up.

  • Margins will see pressure from customer push-back on further price increases as they are currently going through an intense price war. This will be partly offset by continued use of automation and cost-cutting; thus we see margin relatively flat here at 6.0%. Capex is focused on automation, capacity increases and cost efficiencies; this will be increasing significantly, putting pressure on FCF generation.

  • It has been deleveraging steadily since its refinancing in 2024 through EBITDA expansion as well as debt reduction, which puts it closer to 1.5x net leverage (ex. pension liabilities, which add two turns). This means before its capex ramp, it is in relatively good stead.

  • During the year, Hook 2 Sisters (50% chicken rearing JV) was sold by 2SFG to the Boparan Family entity. Because Boparan owned half of Hook 2 Sisters, any excess margin the family took on feed or the bird price was halved back to the bond group through the 50% equity pickup, with a board seat to check it. Now that the family owns 100%, it sets the feed price, the feed price ratchets the bird price the bond group pays, and the family keeps the entire excess margin with no offset and no governance.

  • Our model shows FCF / interest cover falling steadily as a result of this but remaining well above 1.0x; leverage is to remain broadly steady.

Please reach out with any questions.

Karan Pathak, CFA

E: kpathak@sarria.co.uk

T: +44 20 3192 0200

www.sarria.co.uk

Karan PathakBOPARAN